Ionis Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Ionis Pharmaceuticals, Inc. (IONS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 123.99 million shares for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2017-08-09
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-06-30 was 123.99M shares, a 2.64% increase year-over-year.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-06-30 was 120.80M shares.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-03-31 was 120.60M shares, a 1.39% increase year-over-year.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2015-12-31 was 120.20M shares, a 1.66% increase year-over-year.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 120.93M shares, a 1.01% increase from fiscal 2015.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 119.72M shares, a 1.72% increase from fiscal 2014.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 117.69M shares, a 6.51% increase from fiscal 2013.
- Ionis Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 110.50M shares, a 9.87% increase from fiscal 2012.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2017-06-30 | 123.99M shares 10-Q · filed 2017-08-09 | 123.43M shares 10-Q · filed 2017-08-09 | ||
| 2016-12-31 | 120.93M shares 10-K · filed 2017-03-01 | |||
| 2016-06-30 | 120.80M shares 10-Q · filed 2017-08-09 | 120.70M shares 10-Q · filed 2017-08-09 | 120.53M shares derived: average of 3 quarters · filed 2017-08-09 | 120.39M shares derived: average of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | 120.60M shares 10-Q · filed 2016-05-05 | 120.40M shares derived: average of 2 quarters · filed 2017-03-01 | 120.26M shares derived: average of 3 quarters · filed 2017-03-01 | |
| 2015-12-31 | 120.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 120.09M shares derived: average of 2 quarters · filed 2017-03-01 | 119.72M shares 10-K · filed 2017-03-01 | |
| 2015-09-30 | 119.98M shares 10-Q · filed 2015-11-09 | 119.56M shares 10-Q · filed 2015-11-09 | ||
| 2015-03-31 | 118.95M shares 10-Q · filed 2016-05-05 | 118.59M shares derived: average of 2 quarters · filed 2017-03-01 | 118.33M shares derived: average of 3 quarters · filed 2017-03-01 | 118.14M shares derived: average of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | 118.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 118.02M shares derived: average of 2 quarters · filed 2017-03-01 | 117.88M shares derived: average of 3 quarters · filed 2017-03-01 | 117.69M shares 10-K · filed 2017-03-01 |
| 2014-09-30 | 117.81M shares 10-Q · filed 2015-11-09 | 117.70M shares derived: average of 2 quarters · filed 2015-11-09 | 117.51M shares 10-Q · filed 2015-11-09 | 117.18M shares derived: average of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | 117.59M shares 10-Q · filed 2014-08-04 | 117.36M shares 10-Q · filed 2014-08-04 | 116.97M shares derived: average of 3 quarters · filed 2016-02-26 | 116.54M shares derived: average of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | 117.13M shares 10-Q · filed 2015-05-05 | 116.66M shares derived: average of 2 quarters · filed 2016-02-26 | 116.19M shares derived: average of 3 quarters · filed 2016-02-26 | 114.28M shares derived: average of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | 116.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 115.72M shares derived: average of 2 quarters · filed 2016-02-26 | 113.33M shares derived: average of 3 quarters · filed 2016-02-26 | 110.50M shares 10-K · filed 2016-02-26 |
| 2013-09-30 | 115.26M shares 10-Q · filed 2014-11-07 | 111.90M shares derived: average of 2 quarters · filed 2014-11-07 | 108.61M shares 10-Q · filed 2014-11-07 | |
| 2013-06-30 | 108.54M shares 10-Q · filed 2014-08-04 | 105.22M shares 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | 101.88M shares 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | 100.58M shares 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |